Open the mobile version, with barcode scanning
Class II Terminated

Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01

Why: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Company
CARDINAL HEALTHCARE
Dublin, OH, United States
Reported
Jan 3, 2024
Recall started
Jan 26, 2022
Ended
Sep 29, 2024
Where sold
Nationwide USA
Amount
1 unit
Full product description
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
Lots / codes affected
Batch 3138326

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.